FRANCE DISEASE INCIDENCE AND PREVALENCE

341 Pages | 97 Exhibits | 2012 Analysis Product Family: Market Reports




OVERVIEW:
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/ disorders in France and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom).

This report is the first in a series of five reports (Disease Incidence and Prevalence for France, Germany, Italy, Spain, and the United Kingdom) that examine the etiology and epidemiology of the most prevalent and costly diseases/disorders in Europe. Topics covered by each of these reports include Alzheimer's disease, anemia, arthritis, asthma, benign prostatic hyperplasia, bronchitis, burns/traumatic wounds, cancer, depression, diabetes, emphysema, erectile dysfunction, glaucoma, heart failure, human immunodeficiency virus/acquired immune deficiency syndrome, hypertension, infertility, multiple sclerosis, osteoporosis, pneumonia, stroke, and transmissible spongiform encephalopathies, among others.

In addition to proprietary data utilized from Medtech Insight's internal resources, many agencies and organizations have provided information including Alzheimer's Disease International, Association France Parkinson, Cystic Fibrosis Europe, European Association of Urology, European Cancer Observatory, European Centre for Disease Prevention and Control, European Society of Cardiology, French Cystic Fibrosis Association, French Society for Research and Sleep Medicine, International Diabetes Federation, International Osteoporosis Foundation, Multiple Sclerosis International Federation, Myasthenia Gravis Association, Organization for Economic Cooperation and Development, and the World Health Organization, among others.

TABLE OF CONTENTS:
INTRODUCTION

1. EUROPEAN HEALTHCARE OVERVIEW

1.1 Healthcare Spending
1.2 Healthcare Facilities and Providers
1.3 Reimbursement Structures and Common Market Directives
1.4 Selected National Healthcare Profiles for France
	1.4.1 Healthcare Organization and Reform
	1.4.2 Hospital/Medical Services and Reimbursement
		1.4.2.1 Public Hospitals
		1.4.2.2 Private Hospitals
	1.4.3 Medical Device Reimbursement

Exhibit 1-1: European Healthcare Expenditures as a Percentage of Gross Domestic Product, Selected Countries, 2002-2008
Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020
Exhibit 1-3: Classification of European Healthcare Providers
Exhibit 1-4: Healthcare Providers within the European Economy
Exhibit 1-5: Average Hospital Length of Stay, Acute Care, Selected Countries, 2002-2008
Exhibit 1-6: European Union, Medical Devices Risk Classification System
Exhibit 1-7: France, Selected National Healthcare Statistics

2. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA

2.1 Anemia
	2.1.1 Iron Deficiency Anemia
		2.1.1.1 Etiology
		2.1.1.2 Epidemiology
	2.1.2 Sickle Cell Anemia
		2.1.2.1 Etiology
		2.1.2.2 Epidemiology
	2.1.3 Thalassemia
		2.1.3.1 Etiology
		2.1.3.2 Epidemiology
2.2 Hemophilia
	2.2.1 Etiology
	2.2.2 Epidemiology

Exhibit 2-1: Europe, Estimated Prevalence of Anemia, by Age and Gender
Exhibit 2-2: France and Europe, Iron Deficiency Anemia, Comparative Incidence and Prevalence
Exhibit 2-3: France and Europe, Sickle Cell Anemia, Comparative Incidence and Prevalence
Exhibit 2-4: France and Europe, Thalassemia, Comparative Prevalence
Exhibit 2-5: France and Europe, Hemophilia, Comparative Incidence and Prevalence

3. CANCER

3.1 Bladder Cancer
	3.1.1 Etiology
	3.1.2 Epidemiology
3.2 Brain Tumors
	3.2.1 Etiology
	3.2.2 Epidemiology
3.3 Breast Cancer
	3.3.1 Etiology
	3.3.2 Epidemiology
3.4 Cervical/Uterine Cancer
	3.4.1 Etiology
	3.4.2 Epidemiology
3.5 Colon/Rectal Cancer
	3.5.1 Etiology
	3.5.2 Epidemiology
3.6 Esophageal Cancer
	3.6.1 Etiology
	3.6.2 Epidemiology
3.7 Kidney/Urothelial Cancer
	3.7.1 Etiology
	3.7.2 Epidemiology
3.8 Leukemia
	3.8.1 Etiology
	3.8.2 Epidemiology
3.9 Lung Cancer
	3.9.1 Etiology
	3.9.2 Epidemiology
3.10 Lymphoma
	3.10.1 Etiology
	3.10.2 Epidemiology
3.11 Melanoma
	3.11.1 Etiology
	3.11.2 Epidemiology
3.12 Oral Cancer
	3.12.1 Etiology
	3.12.2 Epidemiology
3.13 Ovarian Cancer
	3.13.1 Etiology
	3.13.2 Epidemiology
3.14 Pancreatic Cancer
	3.14.1 Etiology
	3.14.2 Epidemiology
3.15 Prostate Cancer
	3.15.1 Etiology
	3.15.2 Epidemiology
3.16 Stomach Cancer
	3.16.1 Etiology
	3.16.2 Epidemiology
3.17 Testicular Cancer
	3.17.1 Etiology
	3.17.2 Epidemiology

Exhibit 3-1: France and Europe, Bladder Cancer, Comparative Incidence and Mortality, by Gender
Exhibit 3-2: France and Europe, Brain Tumors, Comparative Incidence, by Gender
Exhibit 3-3: France and Europe, Breast Cancer, Comparative Incidence and Mortality
Exhibit 3-4: France and Europe, Cervical/Uterine Cancer, Comparative Incidence and Mortality
Exhibit 3-5: France and Europe, Colon/Rectal Cancer, Comparative Incidence and Mortality, by Gender
Exhibit 3-6: France and Europe, Esophageal Cancer, Comparative Incidence and Mortality, by Gender
Exhibit 3-7: France and Europe, Kidney/Urothelial Cancer, Comparative Incidence and Mortality, by Gender
Exhibit 3-8: France and Europe, Leukemia, Comparative Incidence and Mortality, by Gender
Exhibit 3-9: France and Europe, Lung Cancer, Comparative Incidence and Mortality, by Gender
Exhibit 3-10: France and Europe, Lymphoma, Comparative Incidence and Mortality, by Gender
Exhibit 3-11: France and Europe, Melanoma, Comparative Incidence and Mortality, by Gender
Exhibit 3-12: France and Europe, Oral Cancer, Comparative Incidence and Mortality, by Gender
Exhibit 3-13: France and Europe, Ovarian Cancer, Comparative Incidence and Mortality
Exhibit 3-14: France and Europe, Pancreatic Cancer, Comparative Incidence and Mortality, by Gender
Exhibit 3-15: France and Europe, Prostate Cancer, Comparative Incidence and Mortality
Exhibit 3-16: France and Europe, Stomach Cancer, Comparative Incidence and Mortality, by Gender
Exhibit 3-17: France and Europe, Testicular Cancer, Comparative Incidence and Mortality

4. CARDIOVASCULAR DISORDERS

4.1 Cardiac Arrhythmia
	4.1.1 Etiology
	4.1.2 Epidemiology
4.2 Heart Failure
	4.2.1 Etiology
	4.2.2 Epidemiology
4.3 Heart Valve Disorders
	4.3.1 Etiology
	4.3.2 Epidemiology
4.4 Hypertension
	4.4.1 Etiology
	4.4.2 Epidemiology
4.5 Vascular Disorders
	4.5.1 Aneurysms
		4.5.1.1 Etiology
		4.5.1.2 Epidemiology
	4.5.2 Angina Pectoris
		4.5.2.1 Etiology
		4.5.2.2 Epidemiology
	4.5.3 Atherosclerosis
		4.5.3.1 Etiology
		4.5.3.2 Epidemiology
	4.5.4 Myocardial Infarction
		4.5.4.1 Etiology
		4.5.4.2 Epidemiology
	4.5.5 Peripheral Vascular Disease
		4.5.5.1 Etiology
		4.5.5.2 Epidemiology

Exhibit 4-1: France and Europe, Atrial Fibrillation, Comparative Incidence and Prevalence
Exhibit 4-2: France and Europe, Atrial Flutter, Comparative Incidence and Prevalence
Exhibit 4-3: France and Europe, Supraventricular Tachycardia, Comparative Incidence and Prevalence
Exhibit 4-4: France and Europe, Heart Failure, Comparative Incidence and Prevalence, by Gender
Exhibit 4-5: France and Europe, Heart Valve Disorders, Comparative Incidence and Prevalence, by Gender
Exhibit 4-6: France and Europe, Hypertension, Comparative Incidence and Prevalence
Exhibit 4-7: France and Europe, Aneurysms, Comparative Incidence and Prevalence
Exhibit 4-8: Standard Angina Pectoris Classification
Exhibit 4-9: France and Europe, Angina Pectoris, Comparative Incidence and Prevalence, by Gender
Exhibit 4-10: France and Europe, Hypercholesteremia, Comparative Prevalence, by Gender and Selected Country
Exhibit 4-11: France and Europe, Myocardial Infarction, Comparative Incidence and Prevalence, by Gender
Exhibit 4-12: France and Europe, Peripheral Vascular Disease, Comparative Incidence and Prevalence

5. METABOLIC DISORDERS

5.1 Cholelithiasis
	5.1.1 Etiology
	5.1.2 Epidemiology
5.2 Chronic Kidney Disease/End-Stage Renal Disease
	5.2.1 Etiology
	5.2.2 Epidemiology
5.3 Diabetes
	5.3.1 Etiology
	5.3.2 Epidemiology
5.4 Urolithiasis
	5.4.1 Etiology
	5.4.2 Epidemiology

Exhibit 5-1: France and Europe, Cholelithiasis, Comparative Incidence and Prevalence
Exhibit 5-2: France and Europe, Chronic Kidney Disease, Comparative Incidence and Prevalence, by Gender
Exhibit 5-3: France and Europe, Diabetes, Comparative Incidence, by Gender
Exhibit 5-4: France and Europe, Diabetes, Comparative Prevalence, by Share of Population
Exhibit 5-5: France and Europe, Diabetes, Comparative Prevalence, by Gender and Age Group
Exhibit 5-6: France and Europe, Urolithiasis, Comparative Incidence and Prevalence

6. MUSCULOSKELETAL DISORDERS

6.1 Arthritis
	6.1.1 Etiology
	6.1.2 Epidemiology
6.2 Carpal Tunnel Syndrome
	6.2.1 Etiology
	6.2.2 Epidemiology
6.3 Meniscal and Ligament/Tendon Injuries
	6.3.1 Etiology
	6.3.2 Epidemiology
6.4 Duchenne Muscular Dystrophy
	6.4.1 Etiology
	6.4.2 Epidemiology
6.5 Osteoporosis
	6.5.1 Etiology
	6.5.2 Epidemiology

Exhibit 6-1: France and Europe, Rheumatoid Arthritis, Comparative Incidence and Prevalence
Exhibit 6-2: France and Europe, Osteoarthritis of the Knee, Comparative Incidence and Prevalence
Exhibit 6-3: France and Europe, Osteoarthritis of the Hip, Comparative Incidence and Prevalence
Exhibit 6-4: France and Europe, Carpal Tunnel Syndrome, Comparative Incidence and Prevalence
Exhibit 6-5: France and Europe, Meniscal and Ligament/Tendon Injuries of the Knee, Comparative Incidence and Prevalence
Exhibit 6-6: France and Europe, Duchenne Muscular Dystrophy, Comparative Incidence and Prevalence
Exhibit 6-7: France and Europe, Osteoporosis, Comparative Incidence and Prevalence

7. NEUROLOGIC ANDPSYCHIATRIC DISORDERS

7.1 Alzheimer's Disease and Dementia
	7.1.1 Etiology
	7.1.2 Epidemiology
7.2 Amyotrophic Lateral Sclerosis
	7.2.1 Etiology
	7.2.2 Epidemiology
7.3 Bipolar Disorder
	7.3.1 Etiology
	7.3.2 Epidemiology
7.4 Cerebrovascular Disorders
	7.4.1 Arteriovenous Malformation
		7.4.1.1 Etiology
		7.4.1.2 Epidemiology
	7.4.2 Stroke
		7.4.2.1 Etiology
		7.4.2.2 Epidemiology
7.5 Depression
	7.5.1 Etiology
	7.5.2 Epidemiology
7.6 Epilepsy
	7.6.1 Etiology
	7.6.2 Epidemiology
7.7 Huntington's Disease
	7.7.1 Etiology
	7.7.2 Epidemiology
7.8 Hydrocephalus
	7.8.1 Etiology
	7.8.2 Epidemiology
7.9 Multiple Sclerosis
	7.9.1 Etiology
	7.9.2 Epidemiology
7.10 Myasthenia Gravis
	7.10.1 Etiology
	7.10.2 Epidemiology
7.11 Parkinson's Disease
	7.11.1 Etiology
	7.11.2 Epidemiology
7.12 Schizophrenia
	7.12.1 Etiology
	7.12.2 Epidemiology

Exhibit 7-1: 2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender
Exhibit 7-2: 2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender
Exhibit 7-3: France and Europe, Alzheimer's Disease, Comparative Incidence and Prevalence
Exhibit 7-4: France and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence
Exhibit 7-5: France and Europe, Bipolar Disorder, Comparative Incidence and Prevalence
Exhibit 7-6: France and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence
Exhibit 7-7: France and Europe, Stroke, Comparative Incidence and Prevalence
Exhibit 7-8: France and Europe, Depression, Comparative Prevalence
Exhibit 7-9: France and Europe, Epilepsy, Comparative Incidence and Prevalence
Exhibit 7-10: France and Europe, Huntington's Disease, Comparative Incidence and Prevalence
Exhibit 7-11: France and Europe, Hydrocephalus, Comparative Incidence and Prevalence
Exhibit 7-12: France and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence
Exhibit 7-13: France and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence
Exhibit 7-14: France and Europe, Parkinson's Disease, Comparative Incidence and Prevalence
Exhibit 7-15: France and Europe, Schizophrenia, Comparative Incidence and Prevalence

8. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA

8.1 Cataracts
	8.1.1 Etiology
	8.1.2 Epidemiology
8.2 Glaucoma
	8.2.1 Etiology
	8.2.2 Epidemiology

Exhibit 8-1: France and Europe, Cataracts, Comparative Incidence and Prevalence
Exhibit 8-2: France and Europe, Glaucoma, Comparative Incidence and Prevalence

9. REPRODUCTIVE AND GENITOURINARY DISORDERS

9.1 Benign Prostatic Hyperplasia
	9.1.1 Etiology
	9.1.2 Epidemiology
9.2 Endometriosis
	9.2.1 Etiology
	9.2.2 Epidemiology
9.3 Erectile Dysfunction
	9.3.1 Etiology
	9.3.2 Epidemiology
9.4 Infertility
	9.4.1 Etiology
	9.4.2 Epidemiology
9.5 Urinary Incontinence
	9.5.1 Etiology
	9.5.2 Epidemiology

Exhibit 9-1: 2010, Europe, Benign Prostatic Hyperplasia, Incidence, by Age
Exhibit 9-2: France and Europe, Benign Prostatic Hyperplasia, Comparative Incidence and Prevalence
Exhibit 9-3: France and Europe, Endometriosis, Comparative Prevalence
Exhibit 9-4: France and Europe, Erectile Dysfunction, Comparative Incidence and Prevalence
Exhibit 9-5: France and Europe, Infertility, Comparative Incidence and Prevalence
Exhibit 9-6: France and Europe, Urinary Incontinence, Comparative Incidence and Prevalence

10. RESPIRATORY DISORDERS

10.1 Acute Respiratory Distress Syndrome
	10.1.1 Etiology
	10.1.2 Epidemiology
10.2 Apnea
	10.2.1 Etiology
	10.2.2 Epidemiology
10.3 Asthma
	10.3.1 Etiology
	10.3.2 Epidemiology
10.4 Cystic Fibrosis
	10.4.1 Etiology
	10.4.2 Epidemiology
10.5 Emphysema
	10.5.1 Etiology
	10.5.2 Epidemiology
10.6 Pneumothorax
	10.6.1 Etiology
	10.6.2 Epidemiology
10.7 Respiratory Failure
	10.7.1 Etiology
	10.7.2 Epidemiology
10.8 Restrictive Lung Disease
	10.8.1 Etiology
	10.8.2 Epidemiology

Exhibit 10-1: France and Europe, Acute Respiratory Distress Syndrome, Comparative Incidence
Exhibit 10-2: France and Europe, Apnea, Comparative Incidence and Prevalence
Exhibit 10-3: France and Europe, Asthma, Comparative Incidence and Prevalence
Exhibit 10-4: France and Europe, Cystic Fibrosis, Comparative Incidence and Prevalence
Exhibit 10-5: France and Europe, Emphysema, Comparative Prevalence
Exhibit 10-6: France and Europe, Pneumothorax, Comparative Incidence and Prevalence
Exhibit 10-7: France and Europe, Respiratory Failure, Comparative Incidence and Prevalence
Exhibit 10-8: France and Europe, Restrictive Lung Disease, Comparative Incidence and Prevalence

11. WOUNDS

11.1 Diabetic Ulcers
	11.1.1 Etiology
	11.1.2 Epidemiology
11.2 Pressure Ulcers
	11.2.1 Etiology
	11.2.2 Epidemiology
11.3 Surgical Wounds
	11.3.1 Etiology
	11.3.2 Epidemiology
11.4 Traumatic Wounds
	11.4.1 Burns
	11.4.2 Head Injuries, Lacerations, Contusions, and Abrasions

Exhibit 11-1: France and Europe, Diabetic Ulcers, Comparative Incidence and Prevalence
Exhibit 11-2: France and Europe, Pressure Ulcers, Comparative Incidence and Prevalence
Exhibit 11-3: France and Europe, Surgical Wounds, Comparative Incidence
Exhibit 11-4: Classification of Burns, by Mechanism of Injury
Exhibit 11-5: France and Europe, Burns and Acute Traumatic Injury, Comparative Incidence

12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS

12.1 Chronic Bronchitis
	12.1.1 Etiology
	12.1.2 Epidemiology
12.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome
	12.2.1 Etiology
	12.2.2 Epidemiology
12.3 Pneumonia
	12.3.1 Etiology
	12.3.2 Epidemiology
12.4 Transmissible Spongiform Encephalopathies
	12.4.1 Etiology
	12.4.2 Epidemiology
12.5 Tuberculosis
	12.5.1 Etiology
	12.5.2 Epidemiology

Exhibit 12-1: France and Europe, Chronic Bronchitis, Comparative Prevalence
Exhibit 12-2: Acquired Immune Deficiency Syndrome, Indicator Diseases
Exhibit 12-3: France and Europe, Human Immunodeficiency Virus, Comparative Incidence and Prevalence
Exhibit 12-4: France and Europe, Acquired Immune Deficiency Syndrome, Comparative Incidence and Prevalence
Exhibit 12-5: France and Europe, Pneumonia, Comparative Incidence
Exhibit 12-6: France and Europe, Transmissible Spongiform Encephalopathies, Comparative Incidence
Exhibit 12-7: France and Europe, Tuberculosis, Comparative Incidence and Prevalence



Contact Us

Need help finding medtech research? Let us help you!